VanEck Vectors Valuation

VanEck Vectors Biotech ETF -- USA Etf  

USD 116.44  0.21  0.18%

VanEck Vectors Biotech has current Real Value of $101.89 per share. The regular price of the etf is $116.44. At this time the etf appears to be over valued. Macroaxis measures value of VanEck Vectors Biotech from inspecting the etf fundamentals such as Number of Employees of 6, Five Year Return of 13.37% and Price to Earning of 17.66times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
VanEck Vectors Biotech ETF is rated below average in three year return as compared to similar ETFs. It is the top ETF in price to sales as compared to similar ETFs .

Current Market Valuation

VanEck Vectors Biotech Valuation Boundaries
Over Valued
April 24, 2018
116.44
Market Value
101.89
Real Value
Target Price Odds
 Above  Below  
128.08
Upside
VanEck Vectors is not too risky asset. Calculation of real value of VanEck Vectors Biotech is based on 2 months time horizon. Increasing VanEck Vectors Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Net Asset

VanEck Vectors Net Asset Analysis
VanEck Vectors Biotech ETF is the top ETF in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Sector category is currently estimated at about 707.62 Million. VanEck Vectors totals roughly 425.18 Million in net asset claiming about 60% of equities under Sector ETF category.
Check also Trending Equities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.